Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D

Completed · Not applicable

Conditions studied: Crohn's Disease (CD), Ulcerative Colitis (UC)

In brief

This study aims to evaluate the effect of vitamin D3 supplementation on disease activity and quality of life in IBD patients deficient in vitamin D, and also help determine the optimal dose of vitamin D3 for them. Hypothesis: Supplementation of vitamin D3 in IBD patients with hypovitaminosis D can improve their quality of life and decrease IBD activity.

Key facts

Study ID

NCT01877577

Run by

University of California, San Francisco

People needed

30

Starts

2012-04-01

Expected to finish

2013-09-01

Last updated by the study team

2014-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis)
• 18 years of age or older
• 25(OH)D levels <30ng/ml
• willing to give informed written consent

You may not qualify if…

• Age < 18 years
• Women who are pregnant or planning to become pregnant
• Patients already taking vitamin D3 ≥2,000 IU/daily prior to study enrollment

Where it is running

• Community Regional Medical Center, Ambulatory Care Center — Fresno, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.